Not approved in the EU: Another setback for the drug tanezumab
By kontakt [at] artrosportalen [dot] se (The Arthritis Portal) - published 19 October 2021 The painkiller tanezumab was not approved by the European Medicine's Agency. At the beginning of 2021, news came that tanezumab, a new pain medication, would be launched in the US and Europe. However, in March, tanezumab suffered a setback in the United States when the US Food and Drug Administration reject
https://www.arthritisportal.lu.se/article/not-approved-eu-another-setback-drug-tanezumab - 2025-06-07